{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-078847","form_type":"8-K","ticker":"BDTX","cik":"0001701541","company_name":"Black Diamond Therapeutics, Inc.","filed_at":"2026-06-29T20:20:51+00:00","discovered_at":"2026-06-29T20:22:01.435277+00:00","generated_at":"2026-06-29T20:22:24.512099+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"BDTX annual meeting elects directors; Kapil Dhingra elected despite majority withheld votes","bullets":["Shannon Campbell elected as Class III director with 19.3M for, 17.2M withheld; Kapil Dhingra elected with 14.0M for, 22.5M withheld.","Ratification of PwC as auditor approved: 44.4M for, 0.1M against, 0.2M abstain.","Advisory vote on executive compensation passed: 35.1M for, 1.2M against, 0.2M abstain, 8.2M broker non-votes.","Frequency of future say-on-pay set to annual (30.4M for 1-year); company will hold annual advisory votes."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-078847","json":"https://secwatch.observer/filing/0001104659-26-078847.json","markdown":"https://secwatch.observer/filing/0001104659-26-078847.md","text":"https://secwatch.observer/filing/0001104659-26-078847.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1701541/000110465926078847/0001104659-26-078847-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1701541/000110465926078847/tm2619324d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T20:22:24.512099+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}